Electronic monitoring of self-reported mood: the return of the subjective? by unknown
Ortiz and Grof  Int J Bipolar Disord  (2016) 4:28 
DOI 10.1186/s40345-016-0069-x
REVIEW
Electronic monitoring of self-reported 
mood: the return of the subjective?
Abigail Ortiz1* and Paul Grof2,3
Abstract 
This narrative review describes recent developments in the use of technology for utilizing the self-monitoring of 
mood, provides some relevant background, and suggests some promising directions. Subjective experience of mood 
is one of the valuable sources of information about the state of an integrated mind/brain system. During the past cen-
tury, psychiatry and psychology moved away from subjectivity, emphasizing external observation, precise measure-
ment, and laboratory techniques. This shift, however, provided only a limited improvement in the understanding of 
mood disorders, and it appears that self-monitoring of mood has the potential to enrich our knowledge, particularly 
when combined with the advances in technology. Modern technology, with its ability to transfer information from 
the individual directly to the researcher via electronic applications, enables us now to study mood regulation more 
thoroughly. Frequent subjective ratings can be helpful in identifying individualized treatment with effective mood 
stabilizers and recognizing subtypes of mood disorders. The variability of subjective ratings may also help us estimate 
the increased risk of recurrence and guide a tailored treatment.
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Background
Subjective experience of mood is one of the valuable 
sources of information about the state of the mind/brain 
function. While building the foundations of psychiatry 
during the nineteenth century, clinicians paid consid-
erable attention to the subjective feelings of patients. 
Kraepelin, for instance, put emphasis on the subjective 
experience of patients when describing diagnostic enti-
ties (Kraepelin and Diefendorf 1902).
The twentieth century psychiatry and psychology 
attempted to move away from the subjective experience, 
questioning their validity, especially under the influence 
of behaviorism. Researchers tended to neglect subjective 
experience. Introspection was considered mostly unreli-
able and scientifically unsatisfactory. Psychologists in 
particular long viewed self-reports with marked suspi-
cion (Clark and Watson 1991). In addition, there was a 
tendency to accept self-reports only if some physiological 
measurements authenticated them.
Researchers in both fields emphasized external obser-
vation, laboratory techniques, and precise measure-
ment. But despite a century limited predominantly to 
such objective strategies, the yield in terms of under-
standing the nature of mood disorders has been lim-
ited. Even after a century of neurobiological research, 
no single psychobiological measurement has emerged 
that expresses the activity of these complex regulations 
in an integrated way altogether as well as the subjective 
experience of the individual can do. While the search 
for the biological basis of mood disorders continues 
and expands to new areas, there has recently been some 
renaissance of interest in better utilizing the subjective 
experiences of the patients.
With the emergence of mood stabilizers, and when 
behaviorism gradually declined as a leading force, a new 
paradigm started to take place, in which mood—the color 
of the subjective experience—is seen as a rich source 
of information with a rather complex regulation. Mood 
regulation can be conceptualized as a buffering system, 
allowing flexible responses that enable us to adapt to an 
ever-changing range of stimuli (Ortiz et al. 2015). Given 
the complex control of many brain functions, subjective 
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experience of mood as a single expression of integrated 
functions has a special value.
Emotions exert a profound influence on human life 
and human behavior, and markedly alter even major 
economic decisions people make (Lerner et  al. 2015). 
The research interest in mood disorders expanded by 
recognizing the importance of the subjective experience 
and the individual’s moods, to enrich the information 
obtained from objective measurements.
Psychological studies of mood ratings
Emotions are usually viewed as fundamental, distinctly 
subjective affective states of shorter duration, accompa-
nied by bodily expressions and autonomic changes. Ordi-
narily, negative emotions (such as sadness, fear, anger, or 
disgust) comprise only a small fraction of everyday affec-
tive experience in controls. Moods are usually defined as 
affective states that may last from several hours to several 
days and are strongly influenced by external events by 
factors such as stress, social activity, and exercise (Powers 
et al. 2015), as well as from endogenous cycles or rhythms 
(Powers et al. 2015; Murray et al. 2009). It is mood, rather 
than emotions, that provides a better understanding of 
everyday experience.
Psychologists have been carefully investigating serial 
subjective assessments of mood states and have discovered 
interesting correlations (Larsen and Ketelaar 1991). David 
Watson, in particular, examined systematically short-term 
mood fluctuations and their relationship to temperament 
and synthesized a vast body of knowledge (Watson 2000). 
These observations have been generated mostly on cohorts 
without a diagnosed psychiatric illness, but can be con-
sidered extendable to many patients with mood disorders 
treated on an outpatient basis. We extract some of the 
conclusions that may be useful to psychiatric observations.
In psychological research it has been shown that the 
affective experiences of an individual can be subsumed 
under two general dimensions: negative and positive 
mood states (Watson 2000). However, these relevant 
concepts have not yet had much impact on psychiat-
ric research of mood disorders. Negative mood states 
involve the experience of negative emotions and poor 
self-concept. It subsumes a variety of negative emotions 
including anger, contempt, disgust, guilt, and fear. Posi-
tive mood states, as a characteristic that describes how 
we experience positive emotions and interact with others, 
is characterized by enthusiasm, alertness, energetic, and 
active traits. These two dimensions are nearly independ-
ent of each other; it is possible for someone to be high in 
both positive and negative traits; or high in one and low 
in the other; or low in both (Watson 2000). These traits 
have been found to be moderately stable over time and 
across situations.
Within these two dimensions, distinct affective expe-
riences are meaningfully intercorrelated. For instance, 
neuroticism and extraversion traits strongly correlate 
with individual differences in negative and positive emo-
tional experience (Lyubomirsky et  al. 2005). Negative 
affect, a highly non-specific dimension that is common 
to many types of psychopathology, correlates moder-
ately with neuroticism. Negative mood states are much 
more responsive to ongoing stress and current life cri-
ses; in contrast, positive mood states are strongly associ-
ated with social interaction and physical activity (Watson 
1988, 2000).
Clinical applications
In clinical practice, the primary tasks are to identify the 
illness early and treat it effectively. To start with, self-
monitoring of mood can be helpful in clinical practice 
when evaluating whether a given treatment is useful. In 
addition, daily ratings and their appropriate analysis, in 
combination with objective data, will allow, for exam-
ple, to differentiate among offsprings of bipolar parents 
those who will stay well and those who have a high risk 
of developing a mood disorder; to select those patients 
who will be likely stabilized on lithium versus those who 
require neuroleptics or lamotrigine; and to identify time 
periods when a patient is at a high risk of recurrence 
(Ortiz et al. 2016).
Identifying predisposed youth
Minor mood disorders (depression NOS, cyclothymia, 
dysthymia), along with childhood sleep and anxiety 
disorders precede and predict the onset of diagnosa-
ble major mood disorders (Grof et  al. 2009; Duffy et  al. 
2013). Adolescents often experience subthreshold psy-
chiatric symptoms—sadness, irritability, anxiety, ela-
tion, energy changes, and sleep problems—even years 
before a recognizable mood disorder (Duffy 2014). These 
changes cannot be reliably captured retrospectively and 
benefit from daily monitoring prospectively. One such 
prospective mood monitoring study that is underway is 
the True Colors study (Bonsall et  al. 2012, 2015). This 
study uses mobile phone and web-based technology 
to collect self-reported health measures on a daily and 
weekly basis. This monitoring has been well accepted 
by patients, particularly the younger age group who are 
increasingly familiar with widespread mobile devices 
and social media. The investigators expect to find a sig-
nificant difference in mood stability profiles between 
high-risk offspring and controls. Further, in those high-
risk offspring with evidence of mood instability, they 
expect a higher risk of new onsets of diagnosable mood 
episodes over the two years of study. A similar, cross-
sectional study suggests that mood instability may be a 
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prodromal phenotype for BD in the offspring of parents 
with bipolar disorder compared to controls (Birmaher 
et al. 2013; Howes et al. 2011). If young people who are at 
high risk of developing serious and persistent mood dis-
orders could be identified earlier this would enable them 
to receive appropriate, timely treatment, and reduce the 
associated morbidity and mortality, given that the risks of 
complicating addictions, school drop-out, and suicide are 
all greater early in the illness.
Contributing to the choice of an effective stabilizer
Identifying the type of illness and tailoring of a mood sta-
bilizer to the individual clinical profile of a patient with 
bipolar disorder is an example of the utility of daily rat-
ings in clinical practice (Grof 2003). It must be stressed 
that the information critical for the choice of an effective 
stabilizer comes first among the other aspects of clinical 
profile, such as family history, the type of clinical course 
(episodic or non-episodic) or comorbidity (Grof et  al. 
1994). The observations described in this section about 
daily self-report of mood, anxiety, energy, and sleep were 
obtained from over one thousand patients participat-
ing in our clinical research programs. As part of the ini-
tial assessment, every new patient has had to provide a 
minimum of six weeks data to help with the diagnostic 
assessment. The relationship with the treatment outcome 
was investigated in retrospect. Our observations show 
that patients with the classical type of bipolar disorder 
and with episodic, recurrent depressions who can be sta-
bilized very well with lithium salts, show characteristic 
patterns of daily ratings. Both patients and their clini-
cians can usually distinguish between the time when the 
patient is in full remission and when the patient relapses 
(Figs.  1, 2, 3): in remission, patients keep marking their 
mood right in the middle (the point that the patient con-
siders where his/her normal mood is), experiencing dis-
tressing symptoms very rarely. On the contrary, when ill, 
their symptoms keep changing hand-in-hand; i.e., during 
a depressive episode the experience of low mood is most 
of the time associated with the experience of low energy 
and elevated anxiety.
On the other hand, patients with bipolar spectrum 
disease who fail to respond to lithium and require sta-
bilization with neuroleptics or lamotrigine, rarely show 
days fully free of symptoms for any length of time. Some 
deviation from the midline is usually present most of the 
time.
Furthermore, the patients who benefit most from lam-
otrigine often find it difficult to express their daily mood 
by marking a single point. Their symptoms frequently 
show “ultra-rapid” cycling, changing several times a day, 
and would need several points in a day to capture the 
changes. In addition, these patients very often recognize 
and comment on life events and external circumstances 
triggering significant changes in their mood.
Double-blind clinical trials comparing the three groups 
of stabilizers head-to-head and identifying responders 
have not been carried out and are unlike to take place, 
because of the cost and lack of interest. Fortunately, we 
can utilize systematic clinical observations of response as 
they markedly improve clinical practice.
Another interesting approach, similar to the one we 
are currently undertaking, includes the analysis of early 
response of mood instability to mood stabilizers as a new 
test paradigm that incorporates daily ratings and non-
linear analyses (Harrison et al. 2016; Holmes et al. 2011).
Forecasting risk of recurrences in mood disorders
Mood variability patterns are different among patients 
with different diagnoses (Grof et  al. 1994; Katerndahl 
et al. 2007). Several studies have shown that high levels of 
mood regularity (low variability, in other words) are char-
acteristic of disease states particularly in patients with 
major depression (Katerndahl and Wang 2007), posttrau-
matic stress disorder (Cowdry et al. 1991), or panic disor-
der (Katerndahl and Wang 2007).
In bipolar disorder, up until recently, the empha-
sis has been placed on acute episodes of depression or 
mania, underestimating the subtleties of mood changes 
in-between episodes as a key feature of the disorder. 
We have shown different patterns of mood variability 
between healthy controls and euthymic bipolar patients 
in our previous studies: essentially, healthy controls 
showed higher mood variability levels, whereas stable 
bipolar patients showed low mood variability, in keeping 
with a less flexible system (Ortiz et al. 2015). These data 
suggest that the variability of subjective ratings may help 
us estimate the increased risk of recurrence and guide an 
effective, individually tailored treatment. A new protocol 
(Ortiz et al. 2016), currently underway, aims to use non-
linear techniques to study mood variability in patients 
with mood disorders to predict high-risk times for the 
onset of episodes.
Other studies, also in bipolar disorder, have used a 
combination of actigraphy and self-assessment question-
naires a combination of actigraphy and self-assessment 
questionnaires sent by text messaging (Novak et  al. 
2014). Although it is unclear whether these self-assess-
ment questions were previously validated, this is another 
example of the utility of subjective measurements and 
remote monitoring to establish whether a patient is at 
risk for relapse.
This type of approach could be related to better clini-
cal monitoring, aimed at intermittent treatment, with 
few side effects and optimal recovery. Moreover, this 
approach can be particularly valuable to adolescents at 
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risk—either because of a strong family history or previ-
ous episodes and because mobile technology and social 
media are part of their lives.
However, one important limitation of using self-ratings 
and self-monitoring is the severity of mood disorder. Nei-
ther manic nor severely depressed patients are capable of 
providing valid self-ratings of their mood states.
Electronic mood monitoring and utilization of apps
One of the first efforts to include a more comprehen-
sive, electronic self-mood monitoring, medication com-
pliance, and sleep was Chronorecord (Bauer et al. 2005, 
2008; 2012; Whybrow et  al. 2003). Using this approach 
in large, international studies, the authors have produc-
tively analyzed many aspects of bipolar disorder, ranging 
from clinical course (Bauer et al. 2006, 2007, 2010, 2011a, 
b, 2012; Rasgon et al. 2005), treatment adherence (Bauer 
et  al. 2010, 2013a, b, c; Adli et  al. 2005), sleep (Bauer 
et al. 2006, 2008, 2009), among others (Conell et al. 2016; 
Bauer et  al. 2005, 2006, 2009b, c; Glenn et  al. 2006). 
Other efforts have included the use of life charts by the 
Stanley Foundation Network (Leverich et al. 2001). More 
recently, as previously mentioned, the Oxford group has 
also developed the “True Colors” system, which also 
monitors mood remotely (Holmes et  al. 2011; Miklow-
itz et al. 2012; Moore et al. 2014). True Colors provides 
a way of visualizing mood data over time. The data are 
made available to the patient, which allows the patient 
to be more aware of their mood variability, activity, and 
sleep. It allows them to monitor how much they are 
helped by a new medication or a particular psychologi-
cal treatment. At the same time, creating an automatic 
system that picks up early signs of deterioration from 
self-reports is quite advantageous and will allow to study 
the specific effects of a drug. In this particular case, the 
OxLith trial (Saunders et  al. 2016), is a high intensity 
RCT which seeks to discover new insights into lithium’s 
mechanism of action and eventually generate new leads 
for drug discovery.
Modern technology with its ability to transfer infor-
mation from the individual directly to the researcher via 
electronic applications (“apps”) has moved the investiga-
tions further ahead. They make it relatively easy to col-
lect the subjective rating of symptoms daily and submit 
them directly to automated analysis so that warning signs 
can then be communicated directly to the treatment 
Fig. 1 Mood ratings in clinical remission for lithium responders. When in remission, lithium responders mark their mood right in the middle (the 
point that the patient considers where his/her normal mood is), experiencing distressing symptoms very rarely. On the other hand, in patients with 
bipolar spectrum disease who fail to respond to lithium and require stabilization with neuroleptics (Fig. 2) or lamotrigine (Fig. 3), some deviation 
from the midline is usually present most of the time
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team. Over 165,000 health apps are now directly avail-
able to patients; mental health is the largest group of apps 
for a specific disease state, larger than cardiology, endo-
crine, or other disorders (Torous et al. 2016). Patients are 
already bringing apps, sleep-tracking devices and activity 
monitoring devices to psychiatrists to share their data; 
however, research is needed to determine consistent 
means for evaluating the performance of apps. Currently, 
as a result of the dearth of information on regulatory 
practices for apps, several authors have developed stand-
ardized frameworks for their clinical use (BinDhim et al. 
2015; Lewis and Wyatt 2014; Donker et al. 2013).
Mental health apps have the potential to be useful tools 
to complement clinical practice, but the majority of those 
currently available lack scientific evidence about their 
efficacy (Marley and Farooq 2015). In addition, they have 
a few challenges, including concerns about how the data 
will be used by the app service, lack of medical involve-
ment in app development, patient confidentiality issues, 
clinical risk emerging from the use of apps, and lack of 
evidence-based practice recommendations. Moreover, 
there are societal and ethical implications related to the 
utilization of these for both medical and non-medical 
purposes (Glenn and Monteith 2014).
Researchers from the Copenhagen Affective Disorders 
Research Center developed a smartphone-based system 
which included daily subjective assessments of activity in 
BD patients, as well as a feedback loop between patients 
and clinicians. The system proved to be highly useful 
by patients, with high rates of self-assessment adher-
ence (Bardram et  al. 2013). The authors found that the 
severity of depression and mania ratings correlated with 
smartphone-generated data, including physical activity 
(Faurholt-Jepsen et al. 2014) and voice features (Faurholt-
Jepsen et al. 2016). However, mood monitoring combined 
with a feedback loop system to clinicians did not result 
in decreased depressive or manic symptoms (Faurholt-
Jepsen et al. 2014).
These findings are in keeping with the fact that mobile 
technology is well suited for augmenting the capability of 
the psychiatrist to deliver high-quality care (Hsin et  al. 
2016), and that both sides of the equation are needed in 
order for this enterprise to be successful (Spaniel et  al. 
2015). For this augmentation to work well, the apps 
should be embedded in clinical care, developed in close 
partnership with clinicians and patients, and combined 
with those aspects of the system that we know already 
work well.
Technology can support and enhance clinical practice 
(Torous and Baker 2016), for example, by incorporat-
ing data from the app and physiological data into elec-
tronic medical records. This method can allow a prompt 
Fig. 2 Mood ratings in clinical remission for responders to atypical antipsychotics (AAP). In these patients, even when in clinical remission, some 
deviation from the midline (the point that the patient considers where his/her normal mood is) is usually present most of the time
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detection of mood episodes (Grof et al. 1993), and pos-
sibly allow intermittent treatment, with lithium salts, for 
example, in those patients with a classical type of bipo-
lar illness, which will decrease side effects and improve 
compliance. In the long term, these approaches could 
decrease rates of admission and suicide and will over-
all improve the quality of life of patients with mood 
disorders.
In this context, apps are becoming a technological 
advance enabling us to study mood regulation and to 
treat mood disorders better and more thoroughly.
Conclusions
Subjective experience of mood is one of the valuable 
sources of information about the state of an integrated 
mind/brain system. During the past century, psychiatry 
and psychology moved away from subjectivity, emphasiz-
ing external observation, precise measurement, and labo-
ratory techniques. This shift, however, provided only a 
limited improvement in the understanding of mood dis-
orders, and it appears that self-monitoring of mood has 
the potential to enrich our knowledge, particularly when 
combined with the advances in technology.
We have described three examples in which frequent 
monitoring of subjective mood ratings are being utilized 
in an attempt to identify the offsprings of bipolar parents 
at high risk of becoming later ill, to forecast the time of 
future episodes of illness and to select the optimal mood 
stabilizer for the patient. With the advantages of modern 
technologies, adopting an approach that combines sub-
jective mood ratings and objective data will allow us to 
estimate the risk of recurrence and to guide an effective 
and tailored treatment for patients with mood disorders.
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